ClinVar Miner

Submissions for variant NM_000092.5(COL4A4):c.4080G>A (p.Pro1360=)

gnomAD frequency: 0.46753  dbSNP: rs2228556
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
PreventionGenetics, part of Exact Sciences RCV000253144 SCV000302118 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000329823 SCV000428076 benign Alport syndrome 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000253144 SCV000711921 benign not specified 2016-03-21 criteria provided, single submitter clinical testing p.Pro1360Pro in exon 42 of COL4A4: This variant is not expected to have clinical significance because it has been identified in 55.67% (9183/16494) of South Asi an chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinsti tute.org; dbSNP rs2228556).
GeneDx RCV000253144 SCV000730235 benign not specified 2017-05-09 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Athena Diagnostics Inc RCV000710850 SCV000841156 benign not provided 2017-04-03 criteria provided, single submitter clinical testing
Invitae RCV000710850 SCV001723253 benign not provided 2024-02-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001543307 SCV001761852 benign Autosomal recessive Alport syndrome 2021-07-10 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002494693 SCV002796814 benign Autosomal recessive Alport syndrome; Benign familial hematuria 2021-10-14 criteria provided, single submitter clinical testing
Natera, Inc. RCV000329823 SCV001459918 benign Alport syndrome 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.